Veritas In Silico announced the trademark registration of its proprietary drug delivery system, Perfusio(R). The announcement was made at 12:00 on 28 October 2026, and detailed information was posted in the announcement materials on Nikkei Company Information DIGITAL.
Veritas In Silico announced the trademark registration of its internally developed drug delivery system, Perfusio(R). The text states that the company formally registered the Perfusio trademark.
The announcement was issued at 12:00 on 28 October 2026, with the information presented as announcement materials. It states that detailed information is available through Nikkei Company Information DIGITAL.
The move indicates that the company announced the trademark registration as part of its intellectual property strategy, and further updates may be provided through Nikkei-affiliated information sources.